Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 24 05 2020
accepted: 11 04 2021
entrez: 24 6 2021
pubmed: 25 6 2021
medline: 3 11 2021
Statut: epublish

Résumé

The burden of STIs is particularly high in HIV-infected MSM patients. A recent increase in STIs prevalence has been noticed in the US and western European countries. We aim to assess trends in asymptomatic STIs following the publication of recommendations for STIs screening, i.e. Chlamydia (CT) and gonorrhea (NG). Seventeen centers located in the Paris area participated in the study. All asymptomatic HIV-infected MSM patients attending a follow up consultation were proposed to participated in the study. Asymptomatic patients were included over 2 periods: period 1 from April to December 2015 and period 2 from September to December 2017. Etiologic diagnosis of STIs including hepatitis B, C, syphilis, was performed using a serological test, including a non-treponemal titer with a confirmatory treponemal assay for syphilis. CT and NG were screened using a nucleic acid amplification test (NAATs) on 3 anatomical sites, i.e. urine, rectal and pharyngeal. Overall, 781 patients were included: 490 and 291 in periods 1 and 2 respectively. Asymptomatic CT, NG, and syphilis were diagnosed in 7.5%, 4.8% and, 4.2% respectively. The rate of patients having a multisite asymptomatic infection was 10.2% and 21.1% for CT and NG respectively. The most frequently involved anatomical sites for CT and NG asymptomatic infections were anorectal (66.1% and 55.2% respectively) and pharyngeal (47.4% and 60.5% respectively). CT and NG asymptomatic infection increased by 1.3- and 2-fold respectively between the two periods while syphilis decreased by 3 folds. Our results encourage to reconsider multisite screening for CT and NG in asymptomatic HIV positive MSM as the yield of screening urinary samples only might be low. Despite the more systematic STI screening of asymptomatic HIV positive MSM the prevalence of STI is increasing in MSM in France. Therefore, this strategy has not led to alter CT and NG transmission. The decrease of syphilis might involve self-medication by doxycycline, and the intensification of syphilis screening.

Identifiants

pubmed: 34166379
doi: 10.1371/journal.pone.0250557
pii: PONE-D-20-15558
pmc: PMC8224955
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0250557

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Pers Assess. 1994 Jun;62(3):385-97
pubmed: 8027907
Sex Transm Dis. 2011 Jan;38(1):12-7
pubmed: 20739912
Rev Prat. 2018 Oct;68(8):849-854
pubmed: 30869447
Med Mal Infect. 2017 Nov;47(7):490-493
pubmed: 28943174
MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137
pubmed: 26042815
AIDS. 2018 Aug 24;32(13):1871-1879
pubmed: 29927787
Int J STD AIDS. 2018 Aug;29(9):842-850
pubmed: 29514561
Euro Surveill. 2017 Feb 2;22(5):
pubmed: 28183392
Sex Transm Dis. 2017 Sep;44(9):547-550
pubmed: 28809772
JAMA. 2016 Jul 12;316(2):171-81
pubmed: 27404185
Lancet Infect Dis. 2018 Mar;18(3):308-317
pubmed: 29229440
Clin Infect Dis. 2017 Sep 15;65(6):1053-1054
pubmed: 28510643
Lancet. 2019 Jun 15;393(10189):2428-2438
pubmed: 31056293
Lancet HIV. 2017 Sep;4(9):e402-e410
pubmed: 28747274
Lancet HIV. 2018 Sep;5(9):e482
pubmed: 30215346
Am J Trop Med Hyg. 2017 Sep;97(3):923-926
pubmed: 28820696
Euro Surveill. 2012 Jan 12;17(2):
pubmed: 22264862
BMJ Open. 2018 Jul 23;8(7):e020336
pubmed: 30037863
Infection. 2018 Jun;46(3):341-347
pubmed: 29460228
Clin Infect Dis. 2020 Sep 12;71(6):1461-1468
pubmed: 31629365
J Clin Med. 2014 Dec 12;3(4):1386-91
pubmed: 26237608
Clin Infect Dis. 2020 Apr 15;70(9):1966-1972
pubmed: 31198933
Sex Transm Dis. 2018 Sep;45(9):615-622
pubmed: 29485537
PLoS One. 2018 Oct 15;13(10):e0205863
pubmed: 30321236
AIDS. 2000;14 Suppl 3:S101-14
pubmed: 11086853
PLoS Pathog. 2017 Jul 13;13(7):e1006495
pubmed: 28704569
Sex Transm Dis. 2002 May;29(5):285-7
pubmed: 11984445
Euro Surveill. 2019 Jan;24(5):
pubmed: 30722812
Emerg Infect Dis. 2018 Feb;24(2):193-200
pubmed: 29350138

Auteurs

Eric Farfour (E)

Service de Biologie Clinique, Hôpital Foch, Suresnes, France.

Svetlane Dimi (S)

Centre de Vaccinations Internationales et Médecine de Voyage, Creil, France.

Olivier Chassany (O)

Patient-Reported Outcomes Research, Sorbonne Paris Cité, Université Paris-Diderot, Paris, France.
Unité de Recherche Clinique en Economie de la Santé, Hôpital Hôtel-Dieu, Assistance Publique Hôpital de Paris, Paris, France.

Sébastien Fouéré (S)

Centre for Genital and Sexually Transmitted Diseases, Dermatology Department, APHP Hospital Saint-Louis, Paris, France.

Nadia Valin (N)

Hôpital Saint Antoine, Service des Maladies Infectieuses, Paris, France.

Julie Timsit (J)

Centre for Genital and Sexually Transmitted Diseases, Dermatology Department, APHP Hospital Saint-Louis, Paris, France.

Jade Ghosn (J)

Assistance Publique-Hôpitaux de Paris, Service des Maladies Infectieuses et Tropicales, Groupe Hospitalier Paris Nord Val de Seine, Site Bichat-Claude Bernard, Paris, France.
INSERM UMR 1137 IAME, PRES Sorbonne Paris Cité, Université Paris Diderot, Paris, France.

Claudine Duvivier (C)

APHP-Hôpital Necker-Enfants Malades, Service de Maladies Infectieuses et Tropicales, Centre d'Infectiologie Necker-Pasteur, Paris, France.
IHU Imagine, Paris, France.
Institut Cochin, CNRS 8104, INSERM U1016, RIL Team: Retrovirus, Infection and Latency, Université de Paris, Paris, France.
Institut Pasteur, Centre Médical de l'Institut Pasteur, Paris, France.

Martin Duracinsky (M)

Patient-Reported Outcomes Research, Sorbonne Paris Cité, Université Paris-Diderot, Paris, France.
Unité de Recherche Clinique en Economie de la Santé, Hôpital Hôtel-Dieu, Assistance Publique Hôpital de Paris, Paris, France.
Médecine Interne et Immunologie Clinique, Hôpital Bicêtre, Assistance Publique Hôpital de Paris, Paris, France.

David Zucman (D)

Réseau Ville-Hôpital, Service de Médecine Interne, Hôpital Foch, Suresnes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH